Search Results

There are 2452480 results for: content related to: LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China

  1. You have free access to this content
    LRRK2 in Parkinson’s disease: in vivo models and approaches for understanding pathogenic roles

    FEBS Journal

    Volume 276, Issue 22, November 2009, Pages: 6445–6454, Zhenyu Yue

    Article first published online : 5 OCT 2009, DOI: 10.1111/j.1742-4658.2009.07343.x

  2. Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe

    Human Mutation

    Volume 33, Issue 7, July 2012, Pages: 1087–1098, Justin P. Rubio, Simon Topp, Liling Warren, Pamela L. St. Jean, Daniel Wegmann, Darren Kessner, John Novembre, Judong Shen, Dana Fraser, Jennifer Aponte, Keith Nangle, Lon R. Cardon, Margaret G. Ehm, Stephanie L. Chissoe, John C. Whittaker, Matthew R. Nelson and Vincent E. Mooser

    Article first published online : 4 APR 2012, DOI: 10.1002/humu.22075

  3. You have free access to this content
    Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment

    Journal of Neurochemistry

    Volume 111, Issue 3, November 2009, Pages: 703–715, Christian L. Klein, Giorgio Rovelli, Wolfdieter Springer, Christoph Schall, Thomas Gasser and Philipp J. Kahle

    Article first published online : 27 AUG 2009, DOI: 10.1111/j.1471-4159.2009.06358.x

  4. Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation

    Movement Disorders

    Volume 21, Issue 8, August 2006, Pages: 1144–1147, Ioannis U. Isaias, Riccardo Benti, Stefano Goldwurm, Michela Zini, Roberto Cilia, Paolo Gerundini, Alessio Di Fonzo, Vincenzo Bonifati, Gianni Pezzoli and Angelo Antonini

    Article first published online : 2 MAY 2006, DOI: 10.1002/mds.20909

  5. You have free access to this content
    LRRK2 in Parkinson’s disease: function in cells and neurodegeneration

    FEBS Journal

    Volume 276, Issue 22, November 2009, Pages: 6436–6444, Philip J. Webber and Andrew B. West

    Article first published online : 5 OCT 2009, DOI: 10.1111/j.1742-4658.2009.07342.x

  6. You have free access to this content
    Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein

    Journal of Neurochemistry

    Volume 122, Issue 3, August 2012, Pages: 650–658, Jingwen Niu, Mei Yu, Chunyan Wang and Zhiheng Xu

    Article first published online : 22 JUN 2012, DOI: 10.1111/j.1471-4159.2012.07809.x

  7. You have free access to this content
    Investigation of leucine-rich repeat kinase 2

    FEBS Journal

    Volume 276, Issue 2, January 2009, Pages: 466–478, Vasanti S. Anand, Laurie J. Reichling, Kerri Lipinski, Wayne Stochaj, Weili Duan, Kerry Kelleher, Pooja Pungaliya, Eugene L. Brown, Peter H. Reinhart, Richard Somberg, Warren D. Hirst, Steven M. Riddle and Steven P. Braithwaite

    Article first published online : 8 DEC 2008, DOI: 10.1111/j.1742-4658.2008.06789.x

  8. Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations

    Movement Disorders

    Volume 26, Issue 11, September 2011, Pages: 2026–2031, Javier Ruiz-Martínez, Ana Gorostidi, Estibaliz Goyenechea, Ainhoa Alzualde, Juan José Poza, Francisco Rodríguez, Alberto Bergareche, Fermín Moreno, Adolfo López de Munain and José F. Martí Massó

    Article first published online : 24 MAY 2011, DOI: 10.1002/mds.23773

  9. You have free access to this content
    Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant

    Journal of Neurochemistry

    Volume 116, Issue 2, January 2011, Pages: 304–315, Veronique Daniëls, Renée Vancraenenbroeck, Bernard M. H. Law, Elisa Greggio, Evy Lobbestael, Fangye Gao, Marc De Maeyer, Mark R. Cookson, Kirsten Harvey, Veerle Baekelandt and Jean-Marc Taymans

    Article first published online : 16 DEC 2010, DOI: 10.1111/j.1471-4159.2010.07105.x

  10. LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease

    Movement Disorders

    Volume 24, Issue 7, 15 May 2009, Pages: 1034–1041, Cyrus P. Zabetian, Mitsutoshi Yamamoto, Alexis N. Lopez, Hiroshi Ujike, Ignacio F. Mata, Yuishin Izumi, Ryuji Kaji, Hirofumi Maruyama, Hiroyuki Morino, Masaya Oda, Carolyn M. Hutter, Karen L. Edwards, Gerard D. Schellenberg, Debby W. Tsuang, Dora Yearout, Eric B. Larson and Hideshi Kawakami

    Article first published online : 2 APR 2009, DOI: 10.1002/mds.22514

  11. Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications

    Movement Disorders

    Volume 26, Issue 8, July 2011, Pages: 1386–1397, Zhenyu Yue and M. Lenard Lachenmayer

    Article first published online : 29 APR 2011, DOI: 10.1002/mds.23737

  12. You have free access to this content
    LRRK2 gene variation and its contribution to Parkinson disease

    Human Mutation

    Volume 30, Issue 8, August 2009, Pages: 1153–1160, Coro Paisán-Ruiz

    Article first published online : 21 APR 2009, DOI: 10.1002/humu.21038

  13. You have free access to this content
    Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson’s disease mutations and LRRK2 pharmacological inhibition

    Journal of Neurochemistry

    Volume 120, Issue 1, January 2012, Pages: 37–45, Elizabeth A. Doggett, Jing Zhao, Christina N. Mork, Dongmei Hu and R. Jeremy Nichols

    Article first published online : 11 NOV 2011, DOI: 10.1111/j.1471-4159.2011.07537.x

  14. You have free access to this content
    LRRK2 in Parkinson’s disease: biochemical functions

    FEBS Journal

    Volume 276, Issue 22, November 2009, Pages: 6428–6435, Vasanti S. Anand and Steven P. Braithwaite

    Article first published online : 5 OCT 2009, DOI: 10.1111/j.1742-4658.2009.07341.x

  15. The neuropathology of genetic Parkinson's disease

    Movement Disorders

    Volume 27, Issue 7, June 2012, Pages: 831–842, Markos Poulopoulos, Oren A. Levy and Roy N. Alcalay

    Article first published online : 26 MAR 2012, DOI: 10.1002/mds.24962

  16. Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease

    Movement Disorders

    Volume 27, Issue 8, July 2012, Pages: 1004–1011, David A. Elliott, Woojin S. Kim, Sarsha Gorissen, Glenda M. Halliday and John B.J. Kwok

    Article first published online : 23 APR 2012, DOI: 10.1002/mds.25005

  17. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia

    European Journal of Neurology

    Volume 14, Issue 4, April 2007, Pages: 413–417, S. N. Illarioshkin, M. I. Shadrina, P. A. Slominsky, E. V. Bespalova, T. B. Zagorovskaya, G. Kh. Bagyeva, E. D. Markova, S. A. Limborska and I. A. Ivanova-Smolenskaya

    Article first published online : 23 MAR 2007, DOI: 10.1111/j.1468-1331.2007.01685.x

  18. You have free access to this content
    Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson’s disease R1441C/G mutants

    Journal of Neurochemistry

    Volume 103, Issue 1, October 2007, Pages: 238–247, Xianting Li, Yin-Cai Tan, Shibu Poulose, C. Warren Olanow, Xin-Yun Huang and Zhenyu Yue

    Article first published online : 3 JUN 2007, DOI: 10.1111/j.1471-4159.2007.04743.x

  19. You have free access to this content
    LRRK2 in Parkinson’s disease: genetic and clinical studies from patients

    FEBS Journal

    Volume 276, Issue 22, November 2009, Pages: 6455–6463, Udhaya Kumari and E. K. Tan

    Article first published online : 5 OCT 2009, DOI: 10.1111/j.1742-4658.2009.07344.x

  20. LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2536–2541, Rachel Saunders-Pullman, Matthew J. Barrett, Kaili M. Stanley, Marta San Luciano, Vicki Shanker, Lawrence Severt, Ann Hunt, Deborah Raymond, Laurie J. Ozelius and Susan B. Bressman

    Article first published online : 3 SEP 2010, DOI: 10.1002/mds.23314